KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Gsk (GSK) over the last 11 years, with Q1 2023 value amounting to $0.0.

  • Gsk's EPS (Basic) fell 10000.0% to $0.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $0.0, marking a year-over-year decrease of 10000.0%. This contributed to the annual value of $0.81 for FY2024, which is 4658.67% down from last year.
  • Per Gsk's latest filing, its EPS (Basic) stood at $0.0 for Q1 2023, which was down 10000.0% from $2907.8 recorded in Q1 2022.
  • In the past 5 years, Gsk's EPS (Basic) registered a high of $2907.8 during Q1 2022, and its lowest value of $0.0 during Q1 2023.
  • In the last 3 years, Gsk's EPS (Basic) had a median value of $1811.7 in 2021 and averaged $1655.7.
  • In the last 5 years, Gsk's EPS (Basic) skyrocketed by 6735.87% in 2022 and then tumbled by 10000.0% in 2023.
  • Gsk's EPS (Basic) (Quarter) stood at $1253.6 in 2021, then soared by 131.94% to $2907.8 in 2022, then plummeted by 100.0% to $0.0 in 2023.
  • Its EPS (Basic) stands at $0.0 for Q1 2023, versus $2907.8 for Q1 2022 and $1253.6 for Q4 2021.